About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
The ocean is one of the largest and most mysterious ecosystems on Earth. In the tenth episode of Weizmann in Focus, Dave Doneson describes the fascinating research of Weizmann Profs. Ilan Koren and Assaf Vardi who set sail aboard the Tara schooner to unlock some of these mysteries. They were among a select group of scientists who traveled thousands of kilometers across all the world’s oceans to advance research and increase environmental awareness. The research conducted on board the schooner yielded hundreds of scientific papers as well as a better understanding of the ocean ecosystem and how it impacts the entire planet.
October 31, 2019
Our brains are so primed to recognize faces – or to tell people apart – that we rarely even stop to think about it, but what happens in the brain when it engages in such recognition is still far from understood. In a new study published in Nature Communications, researchers at the Weizmann Institute of Science have shed new light on this issue. They found a striking similarity between the way in which faces are encoded in the brain and successfully performing artificial intelligence (AI) systems known as deep neural networks.
October 30, 2019
As reported in Globes, Prof. Ada Yonath and Evogene Ltd. are partnering to develop a treatment against antibiotic-resistant strains of Staphylococcus.
October 24, 2019
JERUSALEM, Oct. 24 (Xinhua) – Israeli scientists revealed the mechanism of the sea cone snail’s venom, which may lead to new drugs for abnormal heart rate and high blood pressure, the Weizmann Institute of Science (WIS) reported Thursday.
The findings may also lead to the development of safe natural insecticides, because some components of this venom only kill insects, and not mammals.
The findings, published in the scientific journal PNAS, may explain some of the side effects of potassium-blocking drugs, such as heart arrythmia and hypertension drugs, and lead to the development of better ones.
October 24, 2019
October is National Breast Cancer Awareness Month, and people across the world are helping raise awareness and support through runs, walks, events – and, at the Weizmann Institute of Science, through research.
Before breakthroughs in breast cancer research ever appear in the news or on the market, there are cadres of scientists working tirelessly to discover new ways to prevent, diagnose, and treat this all-too-common disease. Here are some of our advances over just the past year:
Our bodies are home to about 100 trillion tiny microbes.
Your body is composed of about 10 million human cells. It’s also home to about 100 trillion tiny microbes, mainly bacteria, that wield astonishing power over your health.
Many influences, from genetics, to diet and stress, contribute to the makeup of your microbiome — the collective community of microbes as personal as a fingerprint.
October 15, 2019
The glycoprotein spike complex of the Ebola virus bound by a neutralizing antibody isolated from a vaccinated individual. Surface representations in grey and pink show the two distinct submits that make the trimeric Ebola spike complex. The heavy and light chains of the neutralizing antibody are shown as blue and green ribbons, respectively. The antibody neutralizes this complex by stapling two adjacent subunits and preventing conformational changes needed by the virus to enter the host cell.
October 07, 2019
The glycoprotein spike complex of the Ebola virus bound by a neutralizing antibody isolated from a vaccinated individual. Surface representations in grey and pink show the two distinct submits that make the trimeric Ebola spike complex. The heavy and light chains of the neutralizing antibody are shown as blue and green ribbons, respectively. The antibody neutralizes this complex by stapling two adjacent subunits and preventing conformational changes needed by the virus to enter the host cell
October 07, 2019
BV can increase the risk of contracting sexually transmitted infections.
Transplanting vaginal fluids from one woman to another could help tackle severe cases of a common bacterial condition, a study has suggested.
Bacterial vaginosis (BV) is thought to affect up to a third of women of reproductive age. It is caused when the balance of microbes in the vagina – known as the vaginal microbiome – becomes disturbed, with a drop in lactobacilli while other bacteria take over.
October 07, 2019
©2020 American Committee for the Weizmann Institute of Science